These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 20838282)
1. The clinical implication and prediction of diffuse splenic FDG uptake during cancer surveillance. Nam HY; Kim SJ; Kim IJ; Kim BS; Pak K; Kim K Clin Nucl Med; 2010 Oct; 35(10):759-63. PubMed ID: 20838282 [TBL] [Abstract][Full Text] [Related]
2. Impact of cytokines on diffuse splenic 18F-fluorodeoxyglucose uptake during positron emission tomography/computed tomography. Pak K; Kim SJ; Kim IJ; Kim DU; Kim K; Kim H Nucl Med Commun; 2013 Jan; 34(1):64-70. PubMed ID: 23076270 [TBL] [Abstract][Full Text] [Related]
3. Correlations between 18F-FDG uptake by bone marrow and hematological parameters: measurements by PET/CT. Murata Y; Kubota K; Yukihiro M; Ito K; Watanabe H; Shibuya H Nucl Med Biol; 2006 Nov; 33(8):999-1004. PubMed ID: 17127173 [TBL] [Abstract][Full Text] [Related]
4. Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer. Du Y; Cullum I; Illidge TM; Ell PJ J Clin Oncol; 2007 Aug; 25(23):3440-7. PubMed ID: 17592153 [TBL] [Abstract][Full Text] [Related]
5. A bone marrow F-18 FDG uptake exceeding the liver uptake may indicate bone marrow hyperactivity. Inoue K; Goto R; Okada K; Kinomura S; Fukuda H Ann Nucl Med; 2009 Sep; 23(7):643-9. PubMed ID: 19629627 [TBL] [Abstract][Full Text] [Related]
6. Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-fluoro-2-deoxy-D-glucose avidity on positron emission tomography/computed tomography. Bar-Shalom R; Kagna O; Israel O; Guralnik L Cancer; 2008 Dec; 113(11):3213-21. PubMed ID: 18924145 [TBL] [Abstract][Full Text] [Related]
7. Analysis of 18F-FDG PET diffuse bone marrow uptake and splenic uptake in staging of Hodgkin's lymphoma: a reflection of disease infiltration or just inflammation? Salaun PY; Gastinne T; Bodet-Milin C; Campion L; Cambefort P; Moreau A; Le Gouill S; Berthou C; Moreau P; Kraeber-Bodéré F Eur J Nucl Med Mol Imaging; 2009 Nov; 36(11):1813-21. PubMed ID: 19499219 [TBL] [Abstract][Full Text] [Related]
8. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer. De Giorgi U; Valero V; Rohren E; Dawood S; Ueno NT; Miller MC; Doyle GV; Jackson S; Andreopoulou E; Handy BC; Reuben JM; Fritsche HA; Macapinlac HA; Hortobagyi GN; Cristofanilli M J Clin Oncol; 2009 Jul; 27(20):3303-11. PubMed ID: 19451443 [TBL] [Abstract][Full Text] [Related]
9. Prevention of brown adipose tissue activation in 18F-FDG PET/CT of breast cancer patients receiving neoadjuvant systemic therapy. Aukema TS; Vogel WV; Hoefnagel CA; Valdés Olmos RA J Nucl Med Technol; 2010 Mar; 38(1):24-7. PubMed ID: 20159933 [TBL] [Abstract][Full Text] [Related]
10. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer. Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736 [TBL] [Abstract][Full Text] [Related]
11. Pediatric FDG PET/CT: physiologic uptake, normal variants, and benign conditions. Shammas A; Lim R; Charron M Radiographics; 2009; 29(5):1467-86. PubMed ID: 19755606 [TBL] [Abstract][Full Text] [Related]
12. Inter-observer variations in FDG-PET interpretation for cancer screening. Suzuki A; Nakamoto Y; Terauchi T; Kawamoto M; Okumura Y; Suzuki Y; Sato T; Takahashi N; Lee J; Senda M; Uno K; Inoue T Jpn J Clin Oncol; 2007 Aug; 37(8):615-22. PubMed ID: 17704533 [TBL] [Abstract][Full Text] [Related]
13. PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance. Israel O; Yefremov N; Bar-Shalom R; Kagana O; Frenkel A; Keidar Z; Fischer D J Nucl Med; 2005 May; 46(5):758-62. PubMed ID: 15872347 [TBL] [Abstract][Full Text] [Related]
14. Schmorl's node may cause an increased FDG activity. Chen YK; Chen HY; Kao CH Clin Nucl Med; 2011 Jun; 36(6):494-5. PubMed ID: 21552037 [TBL] [Abstract][Full Text] [Related]
15. Focal splenic FDG uptake in a patient with Kala-Azar (visceral leishmaniasis). Fuertes J; Garcia-Bennett JR; Iftimie S; Danús M; Abreu JA Clin Nucl Med; 2014 Apr; 39(4):387-90. PubMed ID: 24566400 [TBL] [Abstract][Full Text] [Related]
17. Fluorodeoxyglucose positron emission tomography/computed tomography standardized uptake value in discriminating benign versus malignant lesions: an open and debated issue. Bertagna F; Giubbini R Nucl Med Commun; 2011 Jun; 32(6):542-3; author reply 543-4. PubMed ID: 21505288 [No Abstract] [Full Text] [Related]
18. Clinical significance of diffusely increased splenic uptake on FDG-PET. Liu Y Nucl Med Commun; 2009 Oct; 30(10):763-9. PubMed ID: 19654562 [TBL] [Abstract][Full Text] [Related]
19. FDG PET/CT in Primary Splenic Angiosarcoma With Diffuse Involvement of the Spleen. Zhao Q; Dong A; Wang Y; He T; Zuo C Clin Nucl Med; 2017 Oct; 42(10):815-817. PubMed ID: 28806241 [TBL] [Abstract][Full Text] [Related]
20. Diffuse FDG uptake of the bilateral atrial walls in a patient with atrial fibrillation. Dong A; Zhao T; Gong J; Zuo C Clin Nucl Med; 2014 Feb; 39(2):167-9. PubMed ID: 24217538 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]